Skip to main content

Table 3 Sensitivity analysis to compare primary and secondary outcomes for the patients who received 1 and 2 g of ceftriaxone solely for the treatment of community-onset pneumonia

From: 1g versus 2 g daily intravenous ceftriaxone in the treatment of community onset pneumonia – a propensity score analysis of data from a Japanese multicenter registry

 

1 g

(n = 94)

2 g

(n = 94)

absolute difference

p value

Primary Outcome

 Cure rate (%)

88.9

91.5

−2.6 (−6.0, 11.3)

0.549 for superiority

Secondary Outcomes

 Length of hospital stay (days)

18

26

−9 (−2, −15)

0.007

 Duration of antibiotic treatment (days)

7

8

0 (−1, 1)

0.589

 In-hospital mortality (%)

7.9

3.2

4.7 (−2.0, 11.3)

0.168